Twist Bioscience TWST 深 滬
已收盤 04-02 16:00:00 美东时间
50.21
+0.670
+1.35%
華盛通- 最 高51.00
- 今 開46.99
- 成交量 97.07万股
- 最 低 46.56
- 昨 收 49.54
- 總市值 30.78亿
- 52周最高 57.88
- 市盈率 靜 --
- 換手率 1.58%
- 52周最低 23.30
- 委 比 -3.56%
- 總股本 6131.17万
- 歷史最高 214.07
- 量 比 0.83
- 振 幅 8.96%
- 歷史最低 11.46
- 每 手 1
- 風險率 6.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names
Cathie Wood’s ARK Invest actively rotated out of large-cap technology, crypto-linked equities, and consumer internet names during the last week, while only selectively adding a few names. The firm’s...
03-31 18:35
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $55
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $50 to $55.
03-30 23:21
Cathie Wood's weekly recap: adds AMD, CRSP; cuts PINS, PD, TER
Similar to the trends during the last few weeks, Cathie Wood’s ARK exchange-traded funds continued to step up bets on AI and biotech names. Following last week's moves, the fund chopped holdings in en...
02-23 20:46
Twist Bioscience falls after over $2M insider sale
Twist Bioscience (TWST) lost ~7% in the premarket on Friday after its Senior Vice President of Human Resources, Paula Green, sold more than $2M worth of company stock. Green, who has served the DNA-ba...
02-20 22:21
Cathie Wood Buys The Dip in AMD, Ark Loads Up On Coinbase — But Scales Back On Airbnb
On Tuesday, Feb. 17, 2026, Ark Invest snapped up $21M in AMD, Broadcom, and Coinbase while trimming its Airbnb position.
02-18 10:19
Twist Bioscience rises on licensing deal for antibody discovery platform
Shares of Twist Bioscience (TWST) spiked on Tuesday after the company announced a cash-and-stock transaction to obtain licensing rights to an antibody discovery platform developed by Invenra, a Madiso...
02-18 01:05
Twist Bioscience Licenses Invenra's B‑Body Platform To Expand Antibody Discovery Services
B-Body® platform complements Twist's antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeuticsPlatform to power high-throughput
02-17 20:09
Twist Bioscience acquires 6% stake in Invenra with stock purchase
Twist Bioscience acquires 6% stake in Invenra with stock purchase Twist Bioscience Corporation has acquired an approximately 6% ownership stake in Invenra through a preferred stock purchase from existing Invenra shareholders, valued at $13.8 million in Twist common stock. Additionally, Twist will pr
02-17 20:00
Twist Bioscience CFO Adam Laponis Reports Sale of Common Shares
Twist Bioscience CFO Adam Laponis Reports Sale of Common Shares Adam Laponis, Chief Financial Officer of Twist Bioscience Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Techno
02-14 06:11
